176 related articles for article (PubMed ID: 35972650)
41. Design, synthesis and evaluation of novel deferasirox derivatives with high antifungal potency in vitro and in vivo.
Ni T; Chi X; Wu H; Xie F; Bao J; Wang J; Ji Z; Li L; Wang X; Yan L; Hao Y; Zhang D; Jiang Y
Eur J Med Chem; 2024 Jan; 264():116026. PubMed ID: 38070429
[TBL] [Abstract][Full Text] [Related]
42. Antifungal Peptide SP1 Damages Polysaccharide Capsule of Cryptococcus neoformans and Enhances Phagocytosis of Macrophages.
Liu Y; Zhang Y; Zhao X; Lu W; Zhong Y; Fu YV
Microbiol Spectr; 2023 Mar; 11(2):e0456222. PubMed ID: 36916981
[TBL] [Abstract][Full Text] [Related]
43. In vitro synergistic effect of minocycline combined with antifungals against Cryptococcus neoformans.
Tan L; Shi H; Chen M; Wang Z; Yao Z; Sun Y
J Mycol Med; 2022 Mar; 32(1):101227. PubMed ID: 34800920
[TBL] [Abstract][Full Text] [Related]
44. Effects of Pimenta pseudocaryophyllus (Gomes) L. R. Landrum, on melanized and non-melanized Cryptococcus neoformans.
de Fátima Lisboa Fernandes O; Costa CR; de Souza Lino Junior R; Vinaud MC; Hasimoto E Souza LK; de Paula JA; do Rosário Rodrigues Silva M
Mycopathologia; 2012 Dec; 174(5-6):421-8. PubMed ID: 22932958
[TBL] [Abstract][Full Text] [Related]
45. Effective inhibition of Cbf-14 against Cryptococcus neoformans infection in mice and its related anti-inflammatory activity.
Yu C; Wei S; Han X; Liu H; Wang M; Jiang M; Guo M; Dou J; Zhou C; Ma L
Fungal Genet Biol; 2018 Jan; 110():38-47. PubMed ID: 29221882
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of antifungal activity of cinnamaldehyde against Cryptococcus neoformans var. grubii.
Neelabh ; Singh K
Folia Microbiol (Praha); 2020 Dec; 65(6):973-987. PubMed ID: 32617865
[TBL] [Abstract][Full Text] [Related]
47. Comparative antifungal susceptibility analyses of Cryptococcus neoformans VNI and Cryptococcus gattii VGII from the Brazilian Amazon Region by the Etest, Vitek 2, and the Clinical and Laboratory Standards Institute broth microdilution methods.
Nishikawa MM; Almeida-Paes R; Brito-Santos F; Nascimento CR; Fialho MM; Trilles L; Morales BP; da Silva SA; Santos W; Santos LO; Fortes ST; Cardarelli-Leite P; Lázera MDS
Med Mycol; 2019 Oct; 57(7):864-873. PubMed ID: 30657975
[TBL] [Abstract][Full Text] [Related]
48. Novel antimicrobial peptide DvAMP serves as a promising antifungal agent against Cryptococcus neoformans.
Yang L; Tian Z; Zhao W; Zhang J; Tian C; Zhou L; Jiao Z; Peng J; Guo G
Bioorg Chem; 2023 Sep; 138():106679. PubMed ID: 37329812
[TBL] [Abstract][Full Text] [Related]
49. Effects of microplusin, a copper-chelating antimicrobial peptide, against Cryptococcus neoformans.
Silva FD; Rossi DC; Martinez LR; Frases S; Fonseca FL; Campos CB; Rodrigues ML; Nosanchuk JD; Daffre S
FEMS Microbiol Lett; 2011 Nov; 324(1):64-72. PubMed ID: 22092765
[TBL] [Abstract][Full Text] [Related]
50. Voriconazole inhibits melanization in Cryptococcus neoformans.
Martinez LR; Ntiamoah P; Gácser A; Casadevall A; Nosanchuk JD
Antimicrob Agents Chemother; 2007 Dec; 51(12):4396-400. PubMed ID: 17923488
[TBL] [Abstract][Full Text] [Related]
51. Berberine Antifungal Activity in Fluconazole-Resistant Pathogenic Yeasts: Action Mechanism Evaluated by Flow Cytometry and Biofilm Growth Inhibition in Candida spp.
da Silva AR; de Andrade Neto JB; da Silva CR; Campos Rde S; Costa Silva RA; Freitas DD; do Nascimento FB; de Andrade LN; Sampaio LS; Grangeiro TB; Magalhães HI; Cavalcanti BC; de Moraes MO; Nobre Júnior HV
Antimicrob Agents Chemother; 2016 Jun; 60(6):3551-7. PubMed ID: 27021328
[TBL] [Abstract][Full Text] [Related]
52. A Peptide from Budding Yeast GAPDH Serves as a Promising Antifungal against Cryptococcus neoformans.
Zhang Y; Zhou L; Liu Y; Zhao X; Lian X; Zhang J; Zhao D; Wang Y; Zhong J; Wang J; Wang H; Wang L; Fu YV
Microbiol Spectr; 2022 Feb; 10(1):e0082621. PubMed ID: 35019693
[TBL] [Abstract][Full Text] [Related]
53. Adaptation to Fluconazole via Aneuploidy Enables Cross-Adaptation to Amphotericin B and Flucytosine in Cryptococcus neoformans.
Yang F; Gritsenko V; Lu H; Zhen C; Gao L; Berman J; Jiang YY
Microbiol Spectr; 2021 Oct; 9(2):e0072321. PubMed ID: 34585947
[TBL] [Abstract][Full Text] [Related]
54. The use of chitosan to damage Cryptococcus neoformans biofilms.
Martinez LR; Mihu MR; Han G; Frases S; Cordero RJ; Casadevall A; Friedman AJ; Friedman JM; Nosanchuk JD
Biomaterials; 2010 Feb; 31(4):669-79. PubMed ID: 19819009
[TBL] [Abstract][Full Text] [Related]
55. Stress tolerance and pathogenic potential of a mannitol mutant of Cryptococcus neoformans.
Chaturvedi V; Flynn T; Niehaus WG; Wong B
Microbiology (Reading); 1996 Apr; 142 ( Pt 4)():937-943. PubMed ID: 8936320
[TBL] [Abstract][Full Text] [Related]
56. Molecular typing, in vitro susceptibility and virulence of Cryptococcus neoformans/Cryptococcus gattii species complex clinical isolates from south-eastern Brazil.
Grizante Barião PH; Tonani L; Cocio TA; Martinez R; Nascimento É; von Zeska Kress MR
Mycoses; 2020 Dec; 63(12):1341-1351. PubMed ID: 32869413
[TBL] [Abstract][Full Text] [Related]
57. Fisetin as a promising antifungal agent against Cryptocococcus neoformans species complex.
Reis MP; Carvalho CR; Andrade FA; Fernandes OF; Arruda W; Silva MR
J Appl Microbiol; 2016 Aug; 121(2):373-9. PubMed ID: 27107205
[TBL] [Abstract][Full Text] [Related]
58. In vitro antifungal activities of inhibitors of phospholipases from the fungal pathogen Cryptococcus neoformans.
Ganendren R; Widmer F; Singhal V; Wilson C; Sorrell T; Wright L
Antimicrob Agents Chemother; 2004 May; 48(5):1561-9. PubMed ID: 15105106
[TBL] [Abstract][Full Text] [Related]
59. Anthraquinones from
de Souza Collares Maia Castelo-Branco D; Dos Santos Araújo G; Fonseca XMQC; de Melo Guedes GM; da Rocha MG; Brilhante RSN; de Aguiar Cordeiro R; Sidrim JJC; Pereira-Neto WA; Rocha MFG
Biofouling; 2021 Sep; 37(8):809-817. PubMed ID: 34634964
[TBL] [Abstract][Full Text] [Related]
60. Human cryptococcosis: relationship of environmental and clinical strains of Cryptococcus neoformans var. neoformans from urban and rural areas.
Delgado AC; Taguchi H; Mikami Y; Myiajy M; Villares MC; Moretti ML
Mycopathologia; 2005 Jan; 159(1):7-11. PubMed ID: 15750727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
